Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension

Journal of Human Hypertension

Volumn 24, Issue 11, 2010, Pages 763-774

  Hong, K W ^a   Jin, H S ^a   Lim, J E ^a   Cho, Y S ^b   Go, M J ^b   Jung, J ^c   Lee, J E ^c   Choi, J ^d   Shin, C ^e   Hwang, S Y ^f   Lee, S H ^g   Park, H K ^a   Oh, B ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c DNA Link Inc   (South Korea)

^d Equispharm Co Ltd   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Hankyong National University   (South Korea)

^g Kyung Hee University College of Medicine   (South Korea)

Author keywords

arginin decarboxylase; association; Non synonymous; SNP

Indexed keywords

ALANINE; ARGININE DECARBOXYLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYSTEINE; PHOSPHOLIPASE D2; SERINE;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; MALE; PROTEIN DOMAIN; PROTEIN STRUCTURE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77958044899     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.9     Document Type: Article

References (39)

1. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB. Genes and hypertension. Curr Pharm Des 2003; 9(21): 1679-1689.
2. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11): 1983-1992.
3. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344(8915): 101-106.
4. Gong M, Hubner N. Molecular genetics of human hypertension. Clin Sci (Lond) 2006; 110(3): 315-326.
5. Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension 2006; 48(1): 14-20.
6. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15(12 Part 2): 1579-1592.
7. Herrmann SM, Nicaud V, Tiret L, Evans A, Kee F, Ruidavets JB et al. Polymorphisms of the beta2 -adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 2002; 20(2): 229-235.
8. Saavedra JM. Studies on genes and hypertension: a daunting task. J Hypertens 2005; 23(5): 929-932.
9. WTCCC. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447(7145): 661-678.
10. Ehret GB, Morrison AC, O'Connor AA, Grove ML, Baird L, Schwander K et al. Replication of the wellcome trust genome-wide association study of essential hypertension: the family blood pressure program. Eur J Hum Genet 2008; 16(12): 1507-1511.
11. Hong KW, Jin HS, Cho YS, Lee JY, Lee JE, Cho NH et al. Replication of the wellcome trust genome-wide association study on essential hypertension in a Korean population. Hypertens Res 2009; 32(7): 570-574.
12. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009; 10(5): 318-329.
13. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ et al. From the cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009; 106(1): 226-231.
14. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, Klopp N et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet 2009; 18(12): 2288-2296.
15. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41(6): 666-676.
16. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009; 41(6): 677-687.
17. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009; 41(5): 527-534.
18. Rabbee N, Speed TP. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 2006; 22(1): 7-12.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 2007; 81(3): 559-575.
20. Jung J, Lee B. Protein structure alignment using environmental profiles. Protein Eng 2000; 13(8): 535-543.
21. Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst 1991; 24: 946-950.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21(2): 263-265.
23. Albeck S, Dym O, Unger T, Snapir Z, Bercovich Z, Kahana C. Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function. Protein Sci 2008; 17(5): 793-802.
24. Regunathan S, Reis DJ. Stimulation of imidazoline receptors inhibits proliferation of human coronary artery vascular smooth muscle cells. Hypertension 1997; 30(2 Part 1): 295-300.
25. Cobos-Puc LE, Villalon CM, Ramirez-Rosas MB, Sanchez- Lopez A, Lozano-Cuenca J, Gomez-Diaz B et al. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats. Eur J Pharmacol 2009; 616(1-3): 175-182.
26. Mukaddam-Daher S, Menaouar A, Paquette PA, Jankowski M, Gutkowska J, Gillis MA et al. Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats. Hypertension 2009; 53(5): 775-781.
27. Rouch AJ, Kudo LH. Agmatine inhibits arginine vasopressin-stimulated urea transport in the rat inner medullary collecting duct. Kidney Int 2002; 62(6): 2101-2108.
28. Gao Y, Gumusel B, Koves G, Prasad A, Hao Q, Hyman A et al. Agmatine: a novel endogenous vasodilator substance. Life Sci 1995; 57(8): PL83-PL86.
29. Sun MK, Regunathan S, Reis DJ. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat. Clin Exp Hypertens 1995; 17(1-2): 115-128.
30. Gerova M, Torok J. Hypotensive effect of agmatine, arginine metabolite, is affected by NO synthase. Physiol Res 2004; 53(4): 357-363.
31. Du G, Huang P, Liang BT, Frohman MA. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell 2004; 15(3): 1024-1030.
32. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS et al. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006; 290(1): R96-R104.
33. Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood) 2001; 226(2): 85-96.
34. Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 2008; 69(7): 1104-1111.
35. Chen CM, Chen IC, Chang KH, Chen YC, Lyu RK, Liu YT et al. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(4): 458-462.
36. Rybakowski JK. BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008; 9(11): 1589-1593.
37. Jiang H, Wang R, Liu Y, Zhang Y, Chen ZY. BDNF Val66Met polymorphism is associated with unstable angina. Clin Chim Acta 2009; 400(1-2): 3-7.
38. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996; 19: 289-317.
39. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995; 147(2): 309-324.